5Metabolic Disease, Diabetes and Deficiencies

FThe cochlea as an end-organ of small vessels

The cochlea depends on a delicate terminal microcirculation, chiefly the stria vascularis, with little collateral supply. Like the retina and the renal glomerulus, it behaves as an end-organ that suffers when small vessels are damaged. This is why diseases that injure the microvasculature — diabetes above all — can present in the ear.

Thinking of the cochlea as a microvascular organ unifies several of this module’s causes. Diabetes thickens and narrows the strial capillaries; hyperlipidaemia clogs and stiffens them; deficiencies of the nutrients needed to build blood, myelin and antioxidant defences leave the cochlea less able to withstand the resulting stress. Tinnitus is often the audible signature of that injury [2013].

TDiabetes and insulin resistance

Diabetes mellitus is the best-evidenced metabolic association. A systematic review and meta-analysis found that type 2 diabetes is significantly associated with hearing loss, consistent with a microvascular and neuropathic injury to the cochlea and auditory nerve [2025]. The damage parallels the diabetic complications seen elsewhere: capillary basement-membrane thickening in the stria, oxidative stress, and a peripheral neuropathy that extends to the eighth nerve.

The pattern is not confined to type 2 disease. Studies of type 1 diabetes also report hearing impairment, prompting the question of whether the ear should be regarded as another microvascular target organ alongside the eye, nerve and kidney [2018]. Tinnitus accompanies this hearing loss and may be the symptom that first brings the patient to attention. Even insulin resistance short of frank diabetes may contribute, which is why glycaemic status deserves attention in metabolically at-risk tinnitus patients.

THyperlipidaemia and cochlear perfusion

Elevated cholesterol and triglycerides compromise cochlear microcirculation through atherosclerotic narrowing, endothelial dysfunction and increased blood viscosity. The same lipid-driven processes that produce coronary and cerebral disease can reduce strial perfusion and add oxidative stress to an already metabolically stretched organ. Several case-control studies have reported higher serum lipids in tinnitus patients than in controls.

The honest caveat is that the evidence linking lipid-lowering therapy to tinnitus improvement is weaker than the association itself. Statins and lifestyle modification are recommended primarily for cardiovascular protection; any tinnitus benefit is a welcome but unproven bonus. Nonetheless a lipid profile is reasonable in a tinnitus patient with cardiovascular risk factors, because it identifies a modifiable contributor and a treatable comorbidity.

CMicronutrient deficiencies: B12, zinc and magnesium

Vitamin B12 is essential for myelin synthesis and methylation; its deficiency can impair auditory nerve conduction and central processing. A pilot randomised study reported symptomatic benefit from B12 supplementation in deficient chronic-tinnitus patients, supporting screening in the elderly, vegans, and those on long-term metformin or proton-pump inhibitors who are prone to deficiency [2016]. The principle is to correct a measured deficiency rather than to supplement blindly.

Zinc has been proposed as a cochlear and central modulator, but the rigorous evidence is sobering: a Cochrane review concluded there is no good evidence that zinc supplementation improves tinnitus in adults [2016]. Magnesium, a vasodilator and NMDA-receptor antagonist, has a plausible protective role but similarly limited human tinnitus data. The clinical message is to test for and correct genuine deficiency, not to prescribe supplements as a reflex.

CA focused metabolic work-up

The pragmatic panel for a tinnitus patient with metabolic risk is short: fasting glucose or HbA1c, a lipid profile, and — where the history suggests it — serum vitamin B12 (with folate). A full blood count and ferritin overlap with the anaemia work-up covered elsewhere in this chapter. Routine zinc and magnesium testing is low-yield unless a specific deficiency is suspected.

Interpret results in context. A mildly abnormal lipid is unlikely to be the sole cause of severe tinnitus, whereas a newly diagnosed diabetes or a frank B12 deficiency is worth treating both for the ear and for the patient’s wider health. The metabolic work-up is most valuable not because it always cures the tinnitus, but because it occasionally uncovers serious systemic disease hiding behind a symptom in the ear.